Mimi P Macias

Drug Design and Discovery in Alzheimer’s Disease

Kenneth J. Witt, M. Z. Ahmad, Eric A. Owens, 2014 .

Poor Safety and Tolerability Hamper Reaching a Potentially Therapeutic Dose in the Use of Thalidomide for Alzheimer's Disease: Results from a Double-Blind, Placebo-Controlled Trial.

Sherye A. Sirrel, H. Shill, M. Sabbagh, 2017, Current Alzheimer research.

Subjects harboring presenilin familial Alzheimer's disease mutations exhibit diverse white matter biochemistry alterations.

M. Sabbagh, B. Ghetti, T. Beach, 2013, American journal of neurodegenerative disease.

Molecular Differences and Similarities Between Alzheimer’s Disease and the 5XFAD Transgenic Mouse Model of Amyloidosis

M. Sabbagh, T. Beach, R. Vassar, 2013, Biochemistry insights.

BACE1 Inhibitors: Attractive Therapeutics for Alzheimer’s Disease

M. Sabbagh, A. Adem, B. Decourt, 2014 .

Increased amphiregulin expression as a biomarker of cholesteatoma activity

Mimi P Macias, R. Gerkin, J. Macias, 2010, The Laryngoscope.

Differential Gene Expression in Cholesteatoma by DNA Chip Analysis

Mimi P Macias, R. Gerkin, J. Macias, 2013, The Laryngoscope.

A cellular model of amyloid precursor protein processing and amyloid-β peptide production

Jason J. Corneveaux, M. Sabbagh, M. Huentelman, 2014, Journal of Neuroscience Methods.